Invention Grant
- Patent Title: Anti-PD-L1 antibodies and methods of use
-
Application No.: US16250779Application Date: 2019-01-17
-
Publication No.: US11078283B2Publication Date: 2021-08-03
- Inventor: Pia Björck , Christine Tan , Erin Filbert , Xiaodong Yang
- Applicant: Apexigen, Inc.
- Applicant Address: US CA San Carlos
- Assignee: Apexigen, Inc.
- Current Assignee: Apexigen, Inc.
- Current Assignee Address: US CA San Carlos
- Agency: Cooley LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/28 ; A61P35/00
Abstract:
Provided are anti-programmed death-ligand 1 (PD-L1) monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of inflammatory and oncological diseases. Specifically, high affinity, humanized anti-PD-L1 antibodies are provided.
Public/Granted literature
- US20190218296A1 ANTI-PD-L1 ANTIBODIES AND METHODS OF USE Public/Granted day:2019-07-18
Information query
